Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) announced that Richard Peters, M.D., Ph.D., has been appointed as the Company's President and Chief ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Comments

Merrimack Names Richard Peters, M.D., Ph.D., as President and CEOJanuary 18, 2017 7:30 AM